HRB National Drugs Library e-newsletter volume 19, issue 12

To view our entire collection of research and access our resources visit our website, Ireland's comprehensive substance use research library. And follow us @HRBdrugslibrary. For all recent additions see our recently added publications page.

Irish-related publications

HSE emerging drug trend monitoring. Year 2 results from the Syringe Analysis Programme 2022.

The identification of injecting trends in the Dublin and Midland Region through the application of syringe analysis methodology. McNamara, Sinead et al (2023) Dublin: Health Service Executive.

HSE Update on the emergence of synthetic opioids on the Irish heroin market

(2023) Dublin: HSE

State of health in the EU synthesis report 2023 and report for Ireland.

European Commission (2023) Luxembourg: Publications Office of the European Union

Promoting addiction recovery through building recovery ready communities

In: EWODOR Conference, 23rd – 24th October 2023, Trinity College, Dublin.

Maharaj, T et a; (2024) Public Health, 227. pp. 38-41. doi.org/10.1016/j.puhe.2023.11.016

Anxious anticipation and parental alcohol abuse: a grounded theory study

Martin, Gráinne (2023) PhD thesis, Dublin City University

Evaluation of a national clinical programme for the management of self-harm in hospital emergency departments: impact on patient outcomes and the provision of care

Cully, Grace et al (2023) BMC Psychiatry, 23. doi.org/10.1186/s12888-023-05340-4

Priority healthcare needs amongst people experiencing homelessness in Dublin, Ireland: a qualitative evaluation of community expert experiences and opinions

Ingram, Carolyn et al (2023) PLoS ONE, 18, (12). doi.org/10.1371/journal.pone.0290599

Healthy Communities Project: impact evaluation report October 2021 - January 2023

(2023) Dublin: TASC.

The experience of drug-related client loss for healthcare professionals who support people in addiction

O'Callaghan, Daniel and Lambert, Sharon (2023) Journal of Substance Use and Addiction Treatment, 158. doi.org/10.1016/j.josat.2023.209236

'K culture', ketamine's prominent yet overlooked role on the Irish drug scene and implications for health

Killeen, Nicki et al (2023) Irish Journal of Medical Science, Early online. doi.org/10.1007/s11845-023-03590-5

Review of the demographic factors and toxicology related to deaths due to pregabalin in Northern Ireland

Huddleston, William Ryan et al (2024) Journal of Forensic and Legal Medicine, 101. doi.org/10.1016/j.jflm.2023.102635

Acute liver failure secondary to the use of unmonitored drugs and herbal supplements: an underreported and serious issue.

Ullah, Kaleem et al (2023) Irish Journal of Medical Science, 192, (6), pp. 2969-2971. doi.org/10.1007/s11845-023-03334-5

Alcohol Action Ireland Sale of Alcohol Bill polling Dec 2023 web.

Ireland Thinks. (2023) Dublin: Alcohol Action Ireland

Evidence to inform deliberative democracy: HRB at the Citizens’ Assembly on Drug Use

Health Research Board. (2023) HRB Blog

Independence in the drugs space

Crainn (2023) UISCE Magazine, 2, (Winter 2023), pp. 44-45.

Hearing the voice of people with living and lived experience of drugs

Naughton, Minister Hildegarde (2023) UISCE Magazine, 2, (Winter 2023), pp. 4-5

Evidence from a smoking management service in a university teaching hospital in Dublin, Ireland monitored by repeat surveys, 1997-2022

Mattson, Ana et al (2023) Preventive Medicine Reports, 36. doi.org/10.1016/j.pmedr.2023.102415

Higher smoking and e-cigarette use among young adults with mental health problems: an analysis of wave 4 of growing up in Ireland, the national longitudinal study of children in Ireland

Hanafin, Joan et al (2023) In: The 8th ESNP European Conference on Tobacco Control, 9-12 October 2023, Florence, Italy

Editorial. Getting to Tobacco 21: an all-policy consensus is needed to reduce unintended consequences

Frazer, Kate et al (2023) Health Promotion International, 38, (6). doi.org/10.1093/heapro/daad154

Survive and thrive podcast

(2023) Dublin: Tallaght Drug & Alcohol Task Force

Gabapentinoids in Ireland 2010 to 2020: an observational study of trends in gabapentinoid prescribing, law enforcement drug seizures and post mortem toxicology

Durand, Louise et al (2023) British Journal of Clinical Pharmacology, Early online. doi.org/10.1111/bcp.15984

Suicide prevention curriculum development for health and social care students: protocol for a scoping review

Gallagher, Kerrie et al (2023) PLoS ONE, 18, (12). doi.org/10.1371/journal.pone.0285231

‘The people, the spaces, the talking!’ Igniting community-based higher education

Murray, Thomas and Brennan, Rebekah (2023) Studies in the Education of Adults, Early online. doi.org/10.1080/02660830.2023.2284022

A film-based intervention (Intinn) to enhance adolescent mental health literacy and well-being: multi-methods evaluation study

Goodwin, John et al (2023) Mental Health Review Journal, Early online, doi.org/10.1108/MHRJ-05-2023-0027

Sláintecare webinar 21 - Development of a Crisis Resolution Team (Mental Health)

Sláintecare, International Foundation for Integrated Care, Health Service Executive (2023) Department of Health.

From access to attitudes: mapping public attitudes towards medical cannabis in Ireland

O'Regan, Natalie (2023) Dublin: The Cannabis Review

North East Inner City initiative’s 2023 progress report

(2023) Dublin: Dublin City Council NEIC Programme Office

HSE data management and performance profile reports 2023

(2023) Dublin: Health Service Executive

Justice plan 2023. Mid-year progress report

(2023) Dublin: Department of Justice

Criminal justice public attitudes survey 2022

Behaviour & Attitudes. (2023) Dublin: Department of Justice

Probation re-offending statistics 2019

(2023) Cork: Central Statistics Office

Coolmine annual report 2022

(2023) Dublin: Coolmine

National Poisons Information Centre annual report 2022

(2023) Dublin: National Poisons Information Centre

Annual stigma and attitudes to mental health survey: five-year (2018 -2022) comparative review

(2023) Dublin: St Patrick's Mental Health Services

Cancer in Ireland 1994-2021: annual report of the National Cancer Registry

(2023) Cork: NCRI.

Tobacco Free Ireland annual report 2022

(2023) Dublin: Department of Health

Sport Ireland anti-doping review 2022

(2023) Dublin: Sport Ireland

International publications

Drug policy evaluation in Europe — topic overview

European Monitoring Centre for Drugs and Drug Addiction. (2023)

Engaging youth as leaders and partners can improve substance use prevention: a call to action to support youth engagement practice and research

Ballard, Parissa J et al (2023) Substance Abuse Treatment, Prevention, and Policy, 18. doi.org/10.1186/s13011-023-00582-7

Family-focused universal substance use prevention in primary care: advancing a pragmatic national healthcare agenda.

Hogue, et al (2023) Prevention Science, Early online. doi.org/10.1007/s11121-023-01584-4

Systematic review and meta-analysis of the relationship between exposure to parental substance use and attention-deficit/hyperactivity disorder in children

Maher, Brion S et al (2023) Prevention Science, Early online. doi.org/10.1007/s11121-023-01605-2

Parents with substance use problems: learning from case reviews

(2023) London: NSPCC Learning

"It would really support the wider harm reduction agenda across the board": a qualitative study of the potential impacts of drug checking service delivery in Scotland

Falzon, Danilo et al (2023) PLoS ONE, 18, (12). doi.org/10.1371/journal.pone.0292812

A rapid review of current engagement strategies with people who use drugs in monitoring and reporting on substance use-related harms

Perri, Melissa et al (2023) Harm Reduction Journal, 20. doi: 10.1186/s12954-023-00902-x

Harm reduction strategies in acute care for people who use alcohol and/or drugs: a scoping review

Crowther, Daniel et al (2023) PLoS ONE, 18, (12). doi.org/10.1371/journal.pone.0294804

An on-line school-based substance use harm reduction programme: the Illicit Project randomized controlled trial results

Debenham, Jennifer et al (2023) Addiction, Early online. doi.org/10.1111/add.16403

Drug consumption rooms. Technical report

EMCDDA, Correlation – European Harm Reduction Network. (2023) Luxembourg: Publications Office of the European Union.

Migrants and drugs: health and social responses

(2023) Lisbon: European Monitoring Centre for Drugs and Drug Addiction

Assessing the risk of COVID-19 reinfection and severe outcomes among individuals with substance use disorders: a retrospective study using real-world electronic health records

Tuan, Wen-Jan et al (2023) BMJ Open, 13, (12). doi.org/10.1136/bmjopen-2023-074993

Advisory: low barrier models of care for substance use disorders

(2023) Rockville, MD: Substance Abuse and Mental Health Services Administration

Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders

Guidelines Review Committee, Mental Health and Substance Use. (2023) Geneva: World Health Organization

Help-seeking for risky alcohol and drug use

(2023) Melbourne: Alcohol and Drug Foundation

Adverse health outcomes among people who inject drugs who engaged in recent sex work: findings from a national survey

Emanuel, E et al (2023) Public Health, 225. pp. 79-86. doi.org/10.1016/j.puhe.2023.09.024

HIV among people who inject drugs: data factsheet

(2023) Lisbon: European Monitoring Centre for Drugs and Drug Addiction

Let communities lead — UNAIDS World AIDS Day report 2023

Joint United Nations Programme on HIV/AIDS. (2023) Geneva: Joint United Nations Programme on HIV/AIDS

Frame shift: focusing on harm reduction and shared decision making for people who use drugs hospitalized with infections

Thakarar, Kinna et al (2023) Clinical Infectious Diseases, Early online. doi.org/10.1093/cid/ciad664

Epidemiology of acute infections in people who inject drugs in Australia

Attwood, Lucy O et al (2023) Drug and Alcohol Review, Early online. doi: 10.1111/dar.13772

Neonatal abstinence syndrome: an insight over impact of maternal substance use

Dumbhare, Omkar and Taksande, Amar (2023) Cureus, 15, (10). doi: 10.7759/cureus.47980

Drug misuse in England and Wales

Office for National Statistics. (2023) ONS website

Adult substance misuse treatment statistics 2022 to 2023: report

(2023) London: Office for Health Improvement & Disparities

Relational practice in health, education, criminal justice, and social care: a scoping review

Lamph, Gary et al (2023) Systematic Reviews, 12. doi: 10.1186/s13643-023-02344-9

Roads to recovery: exploring UK prison rehabilitation and its alternatives

Shepherd, Jake and O'Regan, Niamh (2023) London: Social Market Foundation

Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology

Krawczyk, Noa et al (2023) Addiction Science & Clinical Practice, 18. doi: 10.1186/s13722-023-00422-w

Optimizing digital tools for the field of substance use and substance use disorders: backcasting exercise

Scheibein, Florian et al (2023) JMIR Human Factors, 10. doi.org/10.2196/46678

(2023) Vienna: United Nations Office on Drugs and Crime

The relationship between cryptomarket drug purchase, social networks and adverse drug events: a cross-sectional study

Coney, Leigh et al (2023) International Journal of Drug Policy, 123. doi.org/10.1016/j.drugpo.2023.104258

Off track: shadow report for the mid-term review of the 2019 Ministerial Declaration on drugs

Nougier, Marie and Cots Fernández, Adria (2023) London: International Drug Policy Consortium

Health disparities in one of the world's most progressive countries: a scoping review of mental health and substance use among sexual and gender minority people in the Netherlands

Hughes, Tonda L et al (2023) BMC Public Health, 23. doi.org/10.1186/s12889-023-17466-x

Coming of age in recovery: The prevalence and correlates of substance use recovery status among adolescents and emerging adults

Smith, Douglas C et al (2023) PLoS ONE, 18, (12). doi.org/10.1371/journal.pone.0295330

Responding to nitazenes in the UK drugs market

Holland, Adam and Copeland, Caroline (2023) Transform blog

Cannabinoid – NPS Discovery new drug monograph

(2023) United States: Center for Forensic Science Research & Education

Nitrous oxide abuse: clinical outcomes, pharmacology, pharmacokinetics, toxicity and impact on metabolism

Gernez, Emeline et al (2023) Toxics, 11, (12), 962. doi.org/10.3390/toxics11120962

Benzodiazepine discontinuation and mortality among patients receiving long-term benzodiazepine therapy

Maust, Donovan T et al (2023) JAMA Network Open, 6, (12). doi.org/10.1001/jamanetworkopen.2023.48557

Increased risk of non-fatal overdose associated with non-prescribed benzodiazepine use in Scotland, UK

McAuley, A et al (2023) International Journal of Drug Policy, doi.org/10.1016/j.drugpo.2023.104236

N-Desethyl Etonitazene – NPS Discovery new drug monograph

Krotulski, Alex J et al (2023) United States: Center for Forensic Science Research & Education

IUPHAR-review: the integration of classic psychedelics into current substance use disorder treatment models

Yaden, David B et al (2023) Pharmacological Research, doi.org/10.1016/j.phrs.2023.106998

Adverse childhood experiences and all-cause mortality risk in adulthood

D'Arcy-Bewick, Sinéad et al (2023) Child Abuse & Neglect, 144. doi.org/10.1016/j.chiabu.2023.106386

Breen, Paul and Smith, Rebecca (2023) London: Office of National Statistics

Santamarina, R et al (2023) International Journal of Drug Policy, 123. doi.org/10.1016/j.drugpo.2023.104274

Mortality from leading cancers in districts of England from 2002 to 2019

Rashid, Theo et al (2023) The Lancet Oncology, Early online. doi.org/10.1016/S1470-2045(23)00530-2

Fentanyl and the ‘fourth wave’ of the opioid epidemic

Friedman, Joseph and Shover, Chelsea L (2023) SSA Blog

A novel syndrome associated with prenatal fentanyl exposure

Wadman, Erin et al (2023) Genetics in Medicine Open, 1, (1). doi.org/10.1016/j.gimo.2023.100834

Editorial. Opioid problems are changing in Europe with worrying signals that synthetic opioids may play a more significant role in the future

Griffiths, Paul N et al (2023) Addiction, Early online. doi.org/10.1111/add.16420

Association of globalization with the burden of opioid use disorders 2019. A country-level analysis using targeted maximum likelihood estimation

Barbalat, Guillaume et al (2023) Globalization and Health, 19, 76. doi.org/10.1186/s12992-023-00980-3

Conceptualising retention in treatment with long-acting injectable buprenorphine (for opioid use disorder) as a journey: findings from a longitudinal qualitative study

Parkin, Stephen et al (2023) International Journal of Drug Policy, 122. doi.org/10.1016/j.drugpo.2023.104221

Trends in use of medicines for opioid agonist treatment in Australia, 2013-2022

Bharat, Chrianna et al (2023) International Journal of Drug Policy, 123doi.org/10.1016/j.drugpo.2023.104255

Health-care resource use among patients who use illicit opioids in England, 2010-20: a descriptive matched cohort study

van Hest, Naomi et al (2023) Addiction, Early online. doi.org/10.1111/add.16401

Editorial: Chronic obstructive pulmonary disease in heroin users: an underappreciated issue with clinical ramifications

Darke, Shane et al (2023) Addiction, Early online. doi.org/10.1111/add.16407

Southeast Asia opium survey 2023: cultivation, production, and implications

Regional Office for Southeast Asia and the Pacific (2023) Thailand: United Nations Office on Drugs and Crime

Clinical question: For adults with opioid‐refractory cancer pain, what are the benefits and harms of nabiximols (tetrahydrocannabinol (THC) and cannabidiol (CBD))?

Tort, Sera and Husein-ElAhmed, Husein (2023) Cochrane Clinical Answers, doi.org/10.1002/cca.4366

CPME Policy on adverse health effects of cannabis

Standing Committee of European Doctors (2023) Brussels: CPME

Prenatal alcohol exposure and early-life adversity: a translational perspective for dissecting compounding impacts

Holman, Parker J and Raineki, Charlis (2023) Alcohol: Clinical and Experimental Research, 47, (12), pp. 2227-2230. doi.org/10.1111/acer.15212

Alcohol-use disorders: diagnosis and clinical management of alcohol-related physical complications

National Collaborating Centre for Chronic Conditions. (2023) London: NICE.

Under the influence: system-level effects of alcohol industry-funded health information organizations

Maani, Nason et al (2023) Health Promotion International, 38, (6). doi.org/10.1093/heapro/daad167

Changes in alcohol-specific mortality during the COVID-19 pandemic in 14 European countries

Kilian, Carolin et al (2023) SUCHT, 69, (6), pp. 285-293. doi.org/10.1024/0939-5911/a000841

The selection of statistical models for reporting count outcomes and intervention effects in brief alcohol intervention trials: a review and recommendations

Tan, Lin et al (2023) Alcohol: Clinical and Experimental Research, Early online. doi.org/10.1111/acer.15232

Evaluation outcomes of a Western Australian campaign designed to reduce alcohol use in pregnancy

Pettigrew, Simone et al (2023) Australian and New Zealand Journal of Public Health, doi: 10.1016/j.anzjph.2023.100102

Binge-pattern alcohol consumption and genetic risk as determinants of alcohol-related liver disease

Ding, Chengyi et al (2023) Nature Communications, 14. doi.org/10.1038/s41467-023-43064-x

Language bank: talking about inequalities in alcohol use and harm

(2023) London: Institute of Alcohol Studies

Filling in the gaps. A guide to supporting people experiencing co-occurring alcohol use and self-harm issues

Booker, Lauren and Misell, Andrew (2023) London: Alcohol Change UK

WHO technical manual on alcohol tax policy and administration

(2023) Geneva: World Health Organization

Disentangling the contributions of alcohol use disorder and alcohol-related liver disease towards dementia: a population-based cohort study

Zhao, Sixian et al (2023) Addiction, Early online. doi.org/10.1111/add.16395

Global report on the use of alcohol taxes

(2023) Geneva: World Health Organization

Early closing of hotels: Impacts on alcohol consumption, drunkenness, liver disease and injury mortality

Dunt, David R et al(2023) Drug and Alcohol Review, Early online, doi.org/10.1111/dar.13780

Socio-economic inequalities in smoking and drinking in adolescence: assessment of social network dynamics

Radó, Márta K et al (2023) Addiction, Early online. doi: 10.1111/add.16384

The Netherlands tobacco industry interference index

Garritsen, Heike et al (2023) Utrecht: Trimbos Instituut

Why and how should children be protected from the deluge of vaping related media and marketing overexposure?

White, David et al (2023) Breathe, 19, (4). doi: 10.1183/20734735.0141-2023

Global tobacco industry interference index 2023

Assunta, Mary (2023) Bangkok, Thailand: Global Center for Good Governance in Tobacco Control

Effectiveness of culturally tailoring smoking cessation interventions for reducing or quitting combustible tobacco: a systematic review and meta-analyses

Leinberger-Jabari, Andrea et al (2023) Addiction, Early online. doi.org/10.1111/add.16400

Associations between heavy episodic drinking, drinking while gambling, and risky gambling

Smit, Koen et al (2023) Journal of Gambling Studies, 39, (4), pp. 1597-1610. doi.org/10.1007/s10899-023-10235-w

Gambling treatment need and support in England: main findings and methodology

(2023) Office for Health Improvement & Disparities

Psychological intervention for gambling disorder: a systematic review and meta-analysis.

Eriksen, Jakob W et al (2023) Journal of Behavioral Addictions, 12, (3), pp. 613-630. doi: 10.1556/2006.2023.00034

Copyright © 2024 HRB National Drugs Library. All rights reserved.

The HRB National Drugs Library newsletter is a free subscriber-only monthly email newsletter offering relevant Irish and international news and information on alcohol and other drugs research. E-mail addresses provided for the purpose of subscribing to the newsletter will only be used by the library to distribute the requested information. The newsletter is published by the HRB National Drugs Library, Health Research Board. The library is staffed by qualified information professionals who handle a wide range of enquiries. Not sure what we can do for you? Email us and we will be happy to discuss your information needs.